Christopher Ho

1.4k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Christopher Ho is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, Christopher Ho has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 2 papers in Biochemistry. Recurrent topics in Christopher Ho's work include Receptor Mechanisms and Signaling (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Renin-Angiotensin System Studies (3 papers). Christopher Ho is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Renin-Angiotensin System Studies (3 papers). Christopher Ho collaborates with scholars based in United States, Japan and Czechia. Christopher Ho's co-authors include Theodore W. Kurtz, Stephen C. Benson, Harrihar A. Pershadsingh, Amar G. Chittiboyina, Prashant Desai, Mitchell A. Avery, Michal Pravenec, Nianning Qi, Jiaming Wang and Jiaming Wang and has published in prestigious journals such as Genome Research, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Christopher Ho

8 papers receiving 1.2k citations

Hit Papers

Identification of Telmisartan as a Unique Angiotensin II ... 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Ho United States 8 488 452 373 294 180 8 1.2k
Nianning Qi United States 7 433 0.9× 429 0.9× 379 1.0× 377 1.3× 261 1.4× 8 1.2k
Keiichiro Kataoka Japan 28 689 1.4× 665 1.5× 375 1.0× 432 1.5× 158 0.9× 45 2.1k
Yoshiko Tokutomi Japan 21 487 1.0× 488 1.1× 273 0.7× 392 1.3× 123 0.7× 34 1.6k
Yi‐Fei Dong Japan 20 320 0.7× 494 1.1× 274 0.7× 281 1.0× 100 0.6× 27 1.2k
Fung Ping Leung Hong Kong 22 407 0.8× 338 0.7× 280 0.8× 447 1.5× 86 0.5× 43 1.5k
De‐Zai Dai China 21 537 1.1× 472 1.0× 241 0.6× 330 1.1× 74 0.4× 109 1.4k
Timo P. Hiltunen Finland 19 507 1.0× 407 0.9× 338 0.9× 189 0.6× 78 0.4× 49 1.4k
Gaetano Pannitteri Italy 19 443 0.9× 232 0.5× 186 0.5× 210 0.7× 218 1.2× 26 1.3k
Yoshisuke Haruna Japan 17 441 0.9× 266 0.6× 227 0.6× 350 1.2× 83 0.5× 23 1.6k
Atsushi Numabe Japan 23 330 0.7× 546 1.2× 233 0.6× 246 0.8× 76 0.4× 63 1.5k

Countries citing papers authored by Christopher Ho

Since Specialization
Citations

This map shows the geographic impact of Christopher Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Ho more than expected).

Fields of papers citing papers by Christopher Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Ho. The network helps show where Christopher Ho may publish in the future.

Co-authorship network of co-authors of Christopher Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Ho. A scholar is included among the top collaborators of Christopher Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Ho. Christopher Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kajiya, Takashi, Christopher Ho, Jiaming Wang, Ryan F. Vilardi, & Theodore W. Kurtz. (2011). Molecular and cellular effects of azilsartan. Journal of Hypertension. 29(12). 2476–2483. 51 indexed citations
2.
Arif, Sally A., et al.. (2010). Cardiology: Treatment of Systolic Heart Failure in the Elderly: An Evidence-Based Review. Annals of Pharmacotherapy. 44(10). 1604–1614. 8 indexed citations
3.
Yamamoto, Kōichi, Mitsuru Ohishi, Christopher Ho, Theodore W. Kurtz, & Hiromi Rakugi. (2009). Telmisartan-Induced Inhibition of Vascular Cell Proliferation Beyond Angiotensin Receptor Blockade and Peroxisome Proliferator-Activated Receptor-γ Activation. Hypertension. 54(6). 1353–1359. 34 indexed citations
4.
Benson, Stephen C., et al.. (2008). Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?. Journal of Hypertension. 26(5). 973–980. 31 indexed citations
5.
Pravenec, Michal, J Houštěk, Václav Zı́dek, et al.. (2007). Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Research. 17(9). 1319–1326. 64 indexed citations
6.
Chittiboyina, Amar G., Cássia S. Mizuno, Prashant Desai, et al.. (2006). Design and Synthesis of the First Generation of Dithiolane Thiazolidinedione- and Phenylacetic Acid-Based PPARγ Agonists. Journal of Medicinal Chemistry. 49(14). 4072–4084. 42 indexed citations
7.
Bhagavathula, Narasimharao, Kamalakar C. Nerusu, Ashish Lal, et al.. (2004). Rosiglitazone Inhibits Proliferation, Motility, and Matrix Metalloproteinase Production in Keratinocytes. Journal of Investigative Dermatology. 122(1). 130–139. 48 indexed citations
8.
Benson, Stephen C., Harrihar A. Pershadsingh, Christopher Ho, et al.. (2004). Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity. Hypertension. 43(5). 993–1002. 927 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026